Blend Labs Inc (BLND) concluded trading on Thursday at a closing price of $4.40, with 3.25 million shares of worth about $14.3 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 91.30% during that period and on December 26, 2024 the price saw a loss of about -2.22%. Currently the company’s common shares owned by public are about 252.13M shares, out of which, 208.40M shares are available for trading.
Stock saw a price change of -6.38% in past 5 days and over the past one month there was a price change of -16.67%. Year-to-date (YTD), BLND shares are showing a performance of 72.55% which increased to 81.07% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.08 but also hit the highest price of $5.53 during that period. The average intraday trading volume for Blend Labs Inc shares is 2.49 million. The stock is currently trading -10.86% below its 20-day simple moving average (SMA20), while that difference is down -1.20% for SMA50 and it goes to 29.85% higher than SMA200.
Blend Labs Inc (NYSE: BLND) currently have 252.13M outstanding shares and institutions hold larger chunk of about 43.38% of that.
The stock has a current market capitalization of $1.13B and its 3Y-monthly beta is at 1.35. It has posted earnings per share of -$0.34 in the same period. It has Quick Ratio of 3.21. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BLND, volatility over the week remained 5.98% while standing at 5.71% over the month.
Stock’s fiscal year EPS is expected to rise by 82.96% while it is estimated to increase by 189.67% in next year. EPS is likely to grow at an annualized rate of 20.00% for next 5-years, compared to annual growth of -19.48% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by JMP Securities on December 18, 2024 offering a Mkt outperform rating for the stock and assigned a target price of $7 to it. Coverage by Canaccord Genuity stated Blend Labs Inc (BLND) stock as a Buy in their note to investors on August 12, 2024, suggesting a price target of $4.75 for the stock. On August 09, 2024, William Blair Upgrade their recommendations, while on December 20, 2023, Wells Fargo Upgrade their ratings for the stock with a price target of $3.50. Stock get a Mkt perform rating from Keefe Bruyette on November 14, 2022.
